Abstract
Rationale:
Head and Neck Solitary fibrous tumors (SFT) are very rare. They could be misdiagnosed as hemangiopericytomas (HPC).
Patient concerns:
We report a 60 y o lady presenting with sinonasal mass, causing recurrent profuse bleeding.
Diagnoses:
Hemangioperocytomas versus SFT were among the differentials, according to Radiological studies. Upon Biopsy, the diagnosis of SFT has been adopted.
Interventions:
Salvage pre-operative embolization resulted in bleeding control, bridging the patient to surgery.
Outcomes:
Post-operative course was uneventful, and patient symptoms resolved.
Lessons:
This is the first case report of a sinonasal SFT, where pre-operative embolization has been employed as a salvage procedure. This treatment modality is promising, since it controls bleeding, bridges patient to surgery and decreases blood loss during the surgical procedure.
Keywords: embolization, hemangiopericytomas, solitary fibrous tumor
1. Introduction
Solitary fibrous tumors (SFTs) can occur anywhere in the human body, from the head[1] to the ischioanal fossa.[2,3] These spindle cell tumors were first reported in the pleura in 1931.[3] A similar tumor, hemangiopericytoma (HPC) was described in 1942 as a distinctive neoplasm showing characteristic histologic features, including the “staghorn” branching vascular pattern. Over the years, it has become apparent that HPCs and SFTs share considerable histologic and immunohistochemical features and thus, in the latest WHO classification of head and neck tumors, tumors previously classified as HPC are now classified as SFT.[4,21]
Head and neck SFTs are rare, and infratemporal ones are even rarer. Preoperative diagnosis is difficult and, only in few cases, paraclinical investigations have led to accurate diagnosis.[1,4] However, CD34 expression and positive nuclear STAT6 on immunohistochemistry are features that aid in diagnosis.[5,8]
Preoperative embolization has been reported in few cases. SFT occurring in the sinonasal compartments, act in a benign fashion, and only few patients present with malignant features.[8]
2. Case report
A 60-year-old female patient, presented with a 1-year history of minor recurrent epistaxis, and obstructive nasal symptoms. A fiberoptic nasal endoscopy showed a left nasal cavity mass originating from the maxillary sinus. The mass was brownish in color; it was soft, friable, and did not bleed with manipulation. Further investigation with a computed tomography (CT) scan with intravenous contrast showed a left nasal cavity mass involving the maxillary sinus, pterygopalatine fossa, and infratemporal fossa (Fig. 1A and B). A tansnasal biopsy was diagnostic of SFT, and prompted profuse hemorrhage. Anterior nasal packing failed to control bleeding, and patient required transfusion of 2 blood units. The decision was to proceed with salvage arterial embolization.
Figure 1.

Computed tomography (CT) scan showing a left nasal cavity mass extending to the maxillary sinus, pterygopalatine fossa, and infratemporal fossa (asterisk indicates tumor location in the frontal cut and a black arrow in the transverse cut).
2.1. Embolization Technique
Under local anesthesia with sedation, the right femoral artery was accessed. A sheath was placed in the left common carotid artery, and a 4 Fr catheter was advanced in the external carotid artery. Angiographic evaluation of the tumor was obtained (Fig. 2A). A progreat 2.7 Fr microcatheter was placed in the left internal maxillary artery, and embolization was initiated with spherical 100 to 300 μm embospheres, followed by 300 to 500 μm polyvinyl alcohol. Then, the distal internal maxillary artery was occluded with a 6 mm × 15 cm concerto coil (Fig. 2B and C). Small residual arterial branches remained patent due to cross collaterals.
Figure 2.

A, Pre-embolization angiography showing the vascular appearance of the tumor (white arrow). B, The micocatheter in the left internal maxillary artery (white arrowhead). C, Postembolization angiogram. “×” indicates the microcoil.
Complete and safe resection of the tumor was achieved by performing a maxillectomy with a lateral rhinotomy, using a Weber Ferguson approach, 10 days after the embolization. The postoperative period was uneventful, and the patient was discharged on the 6th postoperative day. Now the patient is on 4 months of follow-up postsurgery; she has complete resolution of her symptoms.
The final pathology again was diagnostic of SFT. The tumor demonstrated a cellular proliferation of bland spindle cells with a low mitotic count and no evidence of necrosis. Immunohistochemical studies showed that the tumor cells were positive for CD34. (Fig. 3A and B).
Figure 3.

A, Low power magnification of the tumor showing a densely cellular proliferation with numerous stellate and staghorn-like vessels (black arrow). The tumor shows no necrosis (H&E 50). B, Immunohistochemistry for CD34 is positive in the tumor cells (200) and around the staghorn vessel (double blue arrow).
It is noteworthy mentioning that patient's consent was obtained before publishing her case. An ethical committee approval is not required when considering publication of case reports, as per rules and regulations of the hospital ethical committee.
3. Discussion
Preoperative diagnosis of SFT remains a difficult task, although some specific diagnostic features on magnetic resonance imaging have been suggested.[11] Complete surgical excision is usually curative. However, more aggressive behavior may be related to the tumor size (>15 cm), mitotic count (>4/10 hpf), presence of necrosis, and patient age (>55 years).[8,10]
Radiotherapy should be reserved for incomplete resections, or for tumors showing malignant features.[6] SFTs occurring in the sinonasal compartments are extremely rare, and act in a benign fashion.[12] In a review of 20 SFTs, none of the nasal cavity tumors showed increased mitotic activity.[8] About 12 cases of paranasal SFT have been published in the last 10 years (Table 1). All cases showed good outcome following surgical resection.
Table 1.
Nasal and paranasal solitary fibrous tumors reported during the last 10 years.

Preoperative embolization has been previously described for patients with HPCs. Hanak et al[20] have demonstrated decreased intraoperative blood loss, following preoperative embolization for patients with intracranial HPC. In this article, preoperative embolization resulted in better outcomes, because necrotic softening facilitates surgical resection. Similarly, this technique showed successful results for spinal,[13] mediastinal,[14] and orbital HPCs.[15] In about 4 articles, preoperative embolization has been used for sinonasal HPC. In almost all cases, the maxillary artery was targeted, and none of the authors mentioned a single morbidity case.[16–19] Some articles stated that preoperative necrosis might result in the release of a large amount of vascular endothelial growth factors (VEGFs), increasing the rate of lymphatic metastases, when bridging patients to orthotropic liver transplantation.[22] However, it seems that lymphatic metastasis is regulated by other factors in addition to VEGF.[23] Furthermore, time to surgery varies considerably between patients awaiting orthotropic liver transplant and patient undergoing surgical resection few days after embolization.[21,22]
Despite these promising individual results, the role of preoperative embolization in sinonasal HPC and SFT is yet to be elucidated.
4. Conclusion
To the best of our knowledge, this is the first case of sinonasal SFT, where preoperative embolization has been employed as a salvage procedure. This treatment modality plays a major role in preoperative diagnosis, results in tumor necrotic softening, and reduces the risk of intraoperative bleeding. Although the role of preoperative embolization is not well defined; however, further studies should evaluate its indication as routine before the excision of SFTs.
Author contributions
Conceptualization: H.A. Nasser, M.A. Natout, v. Najjar, C. Tayar.
Data curation: H.A. Nasser, C. Tayar.
Formal analysis: k. yammine, H.A. Nasser, M.A. Natout.
Investigation: M.A. Natout.
Methodology: U. Hadi, C. Tayar.
Resources: U. Hadi.
Supervision: C. Tayar.
Validation: U. Hadi.
Visualization: U. Hadi.
Writing – original draft: H.A. Nasser.
Writing – review & editing: k. yammine, H.A. Nasser, v. Najjar.
Footnotes
Abbreviations: HPC = hemangiopericytoma, SFT = solitary fibrous tumor, VEGF = vascular endothelial growth factors.
The authors report no conflicts of interest.
References
- [1].Elbuluk O, Abemayor E, Sepahdari AR. Solitary fibrous tumor of the larynx: case report demonstrating the value of MRI in guiding surgical management. Clin Imaging 2013;37:1119–21. [DOI] [PubMed] [Google Scholar]
- [2].Vallat-Decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol 1998;22:1501–11. [DOI] [PubMed] [Google Scholar]
- [3].Yoshida R, Takada H, Iwamoto S, et al. A solitary fibrous tumor in the perianal region with a 13-year follow-up: report of a case. Surg Today 1999;29:642–5. [DOI] [PubMed] [Google Scholar]
- [4].Yan J, Jones RL, Lewis DH, et al. Impact of 18F-FDG PET/CT imaging in therapeutic decisions for malignant solitary fibrous tumor of the pelvis. Clin Nucl Med 2013;38:453455. [DOI] [PubMed] [Google Scholar]
- [5].Asimakopoulos P, Syed MI, Andrews T, et al. Sinonasal glomangiopericytoma: is anything new? Ear Nose Throat J 2016;95:E1–5. [DOI] [PubMed] [Google Scholar]
- [6].Freiser ME, Castaño JE, Whittington EE, et al. Solitary fibrous tumor of the infratemporal fossa. J Radiol Case Rep 2014;8:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Janjua A, Sklar M, MacMillan C, et al. Endoscopic resection of solitary fibrous tumors of the nose and paranasal sinuses. Skull Base 2011;21:129–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Kao Y-C, Lin P-C, Yen S-L, et al. Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumors: a comparative histological, immunohistochemical and molecular study of 36 cases. Histopathology 2016;68:492–501. [DOI] [PubMed] [Google Scholar]
- [9].Coca-Pelaz A, Llorente-Pendás JL, Vivanco-Allende B, et al. Solitary fibrous tumor of the petrous bone: a successful treatment option. Acta Otolaryngol 2011;131:1349–52. [DOI] [PubMed] [Google Scholar]
- [10].Gengler C, Guillou L. Solitary fibrous tumor and haemangiopericytoma: evolution of a concept. Histopathology 2006;48:63–74. [DOI] [PubMed] [Google Scholar]
- [11].Yang BT, Song ZL, Wang YZ, et al. Solitary fibrous tumor of the sinonasal cavity: CT and MRI findings. AJNR Am J Neuroradiol 2013;34:1248–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Bowe SN, Wakely PE, Jr, Ozer E. Head and neck solitary fibrous tumors: diagnostic and therapeutic challenges. Laryngoscope 2012;122:1748–55. [DOI] [PubMed] [Google Scholar]
- [13].El Hindy N, Ringelstein A, Forsting M, et al. Spinal metastasis from malignant meningeal intracranial hemangiopericytoma: one-staged percutaneous Onyx (embolization and resection - a technical innovation. World J Surg Oncol 2013;11:152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Kulshreshtha P, Kannan N, Bhardwaj R, et al. Primary mediastinal hemangiopericytoma treated with preoperative embolization and surgery. Ann Thorac Surg 2014;97:335–8. [DOI] [PubMed] [Google Scholar]
- [15].Jeeva I, Chang BY, Bagdonaite L, et al. Treatment of orbital haemangiopericytoma with surgery and preoperative embolization. Eye (Lond) 2013;27:283–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Kanazawa T, Nishino H, Miyata M, et al. Pathology in focus: haemangiopericytoma of infratemporal fossa. J Laryngol Otol 2001;115:77–9. [DOI] [PubMed] [Google Scholar]
- [17].Gillman G, Pavlovich JB. Sinonasal hemangiopericytoma. Otolaryngol Head NeckSurg 2004;131:1012–3. [DOI] [PubMed] [Google Scholar]
- [18].Ledderose GE, Gellrich D, Holtmannspotter M, et al. Endoscopic resection of sinonasal hemangiopericytoma following preoperative embolization: a case report and literature review. Case Rep Otolaryngology 2013;2013:796713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Al Saad S, Al Hadlaq R, Al-Zaher N. Glomangiopericytoma (hemangiopericytoma) of the maxillary sinus and sinonasal tract. Hematol Oncol Stem Cell Ther 2017;10:96–8. [DOI] [PubMed] [Google Scholar]
- [20].Hanak BW, Haussen DC, Ambekar S, et al. Preoperative embolization of intracranial hemangiopericytomas: case series and introduction of the transtumoral embolization technique. J Neurointerv Surg 2016;8:1084–94. [DOI] [PubMed] [Google Scholar]
- [21].Fletcher CD, Hogendoorn P, Mertens F, et al. WHO Classification of Tumours of Soft Tissue and Bone. 4th edLyon, France: IARC Press; 2013. [Google Scholar]
- [22].Xu M, Doyle MM, Banan B, et al. Neoadjuvant locoregional therapy and recurrent hepatocellular carcinoma after liver transplantation. J Am Coll Surg 2017;225:28–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002;94:819–25. [DOI] [PubMed] [Google Scholar]
